Exchange: OTC·Updated 03:48 PM EST

TLIS Talis Biomedical Corp

$2.84
$1.24
(77.50%)
Today
Reported EarningsNov 14
Vol59,306.00

About TLIS

Talis Biomedical Corp. develops and commercializes innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company was founded on June 26, 2013 and is headquartered in Chicago, IL.
21

Extremely Bearish Sentiment

How do you feel about TLIS?

Advertisement|Remove ads.